Science topic
Serum - Science topic
The clear portion of BLOOD that is left after BLOOD COAGULATION to remove BLOOD CELLS and clotting proteins.
Questions related to Serum
Recently, we generated an antibody in rabbits to detect our research target protein. I performed immunoprecipitation using rabbit serum (containing the target antibody), followed by capture with Protein G Plus agarose. Subsequently, I conducted immunoblotting using the same rabbit serum as the primary antibody and an anti-rabbit IgG HRP for secondary antibody. However, I observed strong signals corresponding to the heavy and light chains. Could anyone advise me on how to eliminate or reduce the detection of these chains?
Dear reader,
Maybe you can help us out w/ an IP-problem that we stumble upon.
We try to do an immuno precipitation of a protein (POI) that is expressed in skin. The Protein G SepharoseTM 4 Fast Flow beads are pre-incubated with patient sera (or monoclonal against POI). After washing the beads are incubated w/ a substrate containing the POI.
This works fine when we use the MoAb, as it results in clear bands at a proper MW .
When we used patients serum that we know it contains IgG against POI. 60 µl of beads are loaded w/ 10 µl serum. We do get a faint signal. So far the good news. We need a stronger signal though.
We expected adding more serum to the beads would result in a better signal, but to our surprise that did not happen. The signal goes down after adding more patients serum!
We also tried mixing in the good-working MoAb w/ various concentrations of (normal healthy) serum. This resulted in a similar result: the POI signal went down after adding more NHS.
The IgG heavy and light bands do get higher in the IP’s w/ increasing amounts of serum. So it is not that the more serum IgG added is not bound to the beads.
Do you have any idea how to counter this problem?
Figure: POI is indicated w/ arrow. Arrowhead: reduced IgG heavy chain. A fixed volume (5 µl) MoAb is mixed with various volumes normal serum (NS). From a similar experiment the result is shown of IP w 10 µl patient serum (PS).
From practical experience in inpatient medicine, it is often observed that patients having chest pain due to acute MI have either a non-suggestive or normal ECG even after a significant time lapse. But the serum troponin I levels show raised values. Is it an expected or known finding?
TGF-β1 is an important factor in diabetic nephropathy. Are TGF-β1 levels elevated or reduced in the serum of T2DM patients?
I’m seeing odd results with my Luminex assay and could use some input.
I diluted serum (control: 1:4–1:20, LPS-treated: 1:4–1:320). Most values were below detection, except the 1:320 LPS-treated serum, which gave a measurable signal.
For lysates (control + LPS-treated), more dilution = higher signal.
Our lab tech ruled out hook effect — no signal drop at higher dilutions, and similar results were seen with human tissue lysates. Spiking showed good linearity, so matrix or hook effect seems unlikely.
Kit manufacturer couldn’t help. Anyone seen this before or know what could be going on?
After transfection, cells are not growing and get sick even in control empty vector transfected cell.
protocol:
1.according to the lipofectamine protocol guide
2.after 30min incubation in serum free DMEM, reaction mix was added and after 6h media was changed with complete DMEM(10% FBS, 1% Pen-strep).


Any precipitation methods to isolate only HDL from serum, avoiding serum or plasma components, mean I need pure HDL.
I used the mirVana miRNA kit to extract miRNAs from rat hippocampal samples.
I'm now considering to extract miRNAs from serum or plasma. From what I read, miRNeasy serum/plasma kit is the best commercial choice https://pmc.ncbi.nlm.nih.gov/articles/PMC8495618/pdf/bm-31-3-030705.pdf . However, I have leftovers of the mirVana isolation kit and I was wondering if you have ever used it to isolate miRNA from serum/plasma samples.
In addition, I'm running low on wash solution 1 and filters . do you know if it's possible to purchase the wash solution 1 and filters alone from the mirVana kit? If not, have you ever tried to use an alternative to wash solution 1? And have you ever used the filters from the Qiagen RNAeasy mini/micro kit as an alternative to the mirVana filters?
Thank you in advance!!
Hi everone,
I need to use human M-CSF(100ng/ml) to induce mononuclear cells differentiation into macrophage.
But the issue is,should be use human serum or fetal bovine serum.
Thanks for your answer!
I've been looking around and the Estrogen ELISA Kit (on Eagles Bioscience) seems like a pretty sound option but I wanted additional opinions. Is it sensitive enough to detect low levels (e.g. in postmenopausal women or periprosthetic fluid)?
I need to work in an arthritis model induce by serum from K/BxN. Do you know where can I purchase K/BxN serum?
Could anyone provide the standard reference range for serum levels of Zn, Ca, Se, Al, Fe, and Cu in young healthy C57BL/6 mice?
I have a line of healthy human astrocytes, and plan to passage it.
I was wondering if any suggestions on how to cryopreserve it?
I use mFreSR from stem cell to freeze the iPSCs and not sure if I can use that for astrocytes too?
I saw a post with comments suggesting 10%DMSO and 90%FBS, but was wondering if the FBS will have any negative effects on human astrocytes and if I need to use a different serum instead, or if washing the cells after thawing will be enough to remove the FBS and limit it's effects.
Thank you,
Mahsa
is it Qiagen miRNeasy Serum/Plasma Advanced Kit or Norgen Plasma/Serum RNA Purification Kit ?
how to quantify ceruloplasmin in serum by SDS-PAGE?
I am trying to measure serum neurofilament light chain in Multiple Sclerosis patients but I cannot find in the current student what is the required volume of the serum from each sample.
We found that we have this kit from Qiagen but labelled for serum/plasma samples. Can I isolate RNA from frozen cells pellet of MCF7 and MDA-MB231 cell lines using an RNA isolation kit intended for serum/plasma use?
I have a couple of questions for anyone who has used NIH-3T3 cells:
1) I have noticed that the recommended supplement for the media is calf serum (not FBS) - what is the rationale for this? What are the consequences of culturing these cells in FBS?
2) When culturing NIH-3T3 cells, does serially passaging the cells lead to any morphological changes or changes in gene expression?
Thanks!
I am currently designing a sandwich ELISA experiment and would like to inquire about the feasibility and potential challenges of using polyclonal antibody serum from the same species as both the capture and detection antibody. Specifically:
- Can polyclonal antibodies derived from the same species be reliably used for both capture and detection without significant interference?
- Are there common issues, such as cross-reactivity or background signal, associated with this setup?
- Would it be advisable to label the detection antibody (e.g., HRP) or use a secondary anti-species antibody for signal generation to minimize potential issues?
Any guidance, relevant literature, or best practices to optimize this configuration would be greatly appreciated.
Currently I am conducting research on the analysis of hydroquinone in facial whitening serum using acetonitrile as a solvent. However, I have not found data on the solubility of hydroquinone in acetonitrile. Can anyone help me with this information? Thank you for the help
Hi all,
I am planning to perform Gelatin Zymography using conditioned media from three different knock out from same cell line. I seeded equal number of cells and collected the conditioned media (serum free) for Gelatin Zymography. Is there any way I can address loading control in this assay. Do people normally quantify protein concentration from the collected conditioned media before loading it into Gel? even if we quantify by BCA, how would I show it in the final figure?
Also, the total volume of my conditioned media is roughly 500 ul. Do we need to concentrate it to, lets say 100 ul, across the set and load equal volume if we do not quantify protein concentration?
Here I am using DMEM with 10% serum and 1% antibiotics.
Hi everyone,
I am seeking advice on the optimal protocol for RNA extraction from human T cells that have been frozen at -70°C. Specifically, would it be more beneficial to culture these cells for 18 to 24 hours in complete media (TexMACS + 10% human serum) with 100 IU of IL-2 before proceeding with RNA extraction, or should I initiate the extraction process immediately after thawing?
Any insights or experiences you could share would be greatly appreciated.
Thank you.
Has anyone worked with the HAC15 cell line (ATCC® CRL-3301 ™)? I need to know if I can grow it with another fetal bovine serum that is not Cosmic Calf Serum
I have applied a general protocol. In short:
20uL of serum were added to 8 volumes of a cold TCA+ Acetone solution. After a light stirring I incubated for 90 minutes at -20 followed by centrifuge at 15,000 rpm for 20 minutes. The pellet was washed with acetone and then lyophilized.
The coloration revealed that the albumin was not completely removed from the serum, and the pellet did not resuspend properly. I tried resuspending the pellet in Laemmli Sample buffer.
Can anyone help me?
Dear all,
I'm putting together an antibody panel to characterise airway epithelium.
I've tried two different p63 antibodies which show mostly unexpected cytoplasmic staining. I would expect 15-30% of epithelial cells to be positive with nuclear staining.
Has anyone else come across cytoplasmic staining in airway epithelium?
Details as follows:
FFPE section of lung tissue. Antigen retrieval done on Leica Bond Rx, blocked in BSA with Dk serum, Triton X-100 and Tween 20.
C1 (blue): DAPI
C2 (green): Ms x p63 (ab735, 1:100)
C3 (red): Rb x p63 (ab124762,1:200)
C4: merge
Thanks!

Hello,
I would like to ask about your experience with the assessment of serum Glypican-3 by ELISA. We have used reagent kits from two different manufacturers and got no results. In the first case, already the standard curve was with many errors (lower concentrations in higher standards). When performing the second analysis, standard curve was ok but all serum samples concentrations were bellow the blank value, and the spiked ones only a bit higher. The plates were prepared by an experienced lab assisstant. Do you have any clue? Thanks a lot!
Anyone tried adapting UMNSAH/DF-1 (Chicken Fibroblast cells) from adherent to suspension cells. Currently we are using Xerumfree TnC bio serum alternative with DMEM. The cells are not adapting from 50:50 adaption stage. Can anyone suggest any growth factor to enhance the growth or any other media form adaption to suspension cells.
What is the relationship between serum cholesterol and systolic blood pressure?
Many prostate cancer cell line, such LnCap, Vcap and LAPC4, are androgen-dependent. While studying drug resistance mechanism especially Enzalutamide resistancen, many literature are using charcoal-stripped serum to support their cell line. How will this impact the outcome? I calculated testosterone concentration in normal 10% FBS-supported medium and find it's actually similar to castrated patient whose testosterone are at 20 ng/dl.
Think of this: clinically defined castrated testosteron level is about 5% to 10% of normal male testosteron level, since some of them are synthesized by adrenal gland and cannot be antagonized by GnRH therapy. And we are adding 5% ~ 10% FBS to medium, actually diluted androgen just like castrated patient.
I'd prefer not buying any separate commercial media because of the cost. Please suggest what growth factors or vitamins can I add to DMEM KO other than glutamax, penstrep and bFGF for the MSCs to grow normally.
Thank you!
Good morning, working on patient serums, I noticed that in western blotting tests the IGs give false positives and unspecific signals. Ask if anyone can give me a methodology to remove these immunoglobulins, considering I have few serum available.
Thank you.
We performed ELISA to assess cytokine release from SIM-A9 microglia cells treated with LPS and amyloid-beta. We used DMEM/F-12 medium with 10% FBS, but did not detect cytokines from amyloid-beta treated cells, while LPS treatment led to greater cytokine secretion. The question remains whether amyloid-beta induces cytokine release in SIM-A9 cells cultured in serum-free medium.
We have encountered an issue with the serum of mice being hemolyzed after the process of centrifugation. Could you please provide guidance to prevent hemolysis ?
I am trying to extract DNA from serum. I found an article that claimed simple extraction can be done in a single tube -
Here they used a solution containing 6M NaI/13mM EDTA/0.5% sodium N-lauroylsarcosine/10 µg glycogen as a carrier/26mM Tris-HCl, pH 8.
But currently, I don't have NaI and glycogen. So, I am thinking of making a solution with KI + EDTA + sodium lauroyl sulfate + Tris-HCl, pH 8. And finally, use Na-acetate and absolute ethanol for the precipitation of DNA.
What consideration should I take into account to use alternative reagents?
And, in their protocol does it mean the final solution containing all reagent should have a pH 8 or it just means the use of Tris-HCL with pH 8?
We have encountered an issue with the serum of mice being hemolyzed after the process of centrifugation. Could you please provide guidance to prevent hemolysis?
i am trying to stain different proteins of interest in human paraffinized section.
my signal should be the vessel only, but regardless of the antibody I get circle shaped spots , I tried antigen retrieval with trypsin, and I tried different dilution of antibodies (1:100-1:1000) and blocking in 5% and 10% donkey serum
why I have those spots? how can I reduce them? I have the same issue at different wave lengths (regardless of secondary antibodies tag)
this is my protocol:
•Thickness of sections : 10µ
•Deparaffinization by heat 55degrees for 20 min then (xylene - xylene: ethanol - ethanol) 10min each*twice
•Hydration (ethanol 95% - 70% - 50% - tab water) 5min each*twice
•Antigen retrieval : citrate buffer 10min microwave then leave in buffer to cool
•Peroxide treatment: 3%H2O2 10min at room temp
•Blocking: 5% Donkey serum + 0.3% Triton-PBS 1 hr RT
•Antibodies:
•Primary in 1%BSA: VWF (1:200)
•Secondary 1:500 of Rabbit 594
We have developed an orally delivered compound that elevates serum nitric oxide where the NO has a circulating half-life of ~5 hours.
Hello,
So, I am analyzing serum proteomics with MS from autism mouse models and trying to compare that to human serum data. So its:
Differentially expressed proteins in human serum vs. differentially expressed proteins in mouse model serum
I already got the data. The experiment is already done. No time to re-do any experiment. Is there a way, a tool, to translate the mouse protein data into a human data? Considering the analogous proteins and what not? I'm working with UniProt accession numbers...
If there is like a tool where you drag in the uniprot accession numbers and converts it into its human counterpart protein, or a paper that describes such a method, it would be of great help! Almost out of my depth here...
Thanks,
Andrew
I have tried to optimize the serum free dmem which is the best but i am afraid the secretory profile has too much variations.
Greetings all,
My group has been trying to reproduce 3t3-L1 cell (preadipocytes) differentiation. The typical protocol involves 3 steps: the first step and second step both last for 2 days, and the third step varies in its time since it is more of a maintaining stage for the cells. This protocol is mature and used by many scientists, though details could vary by individuals, the general scheme is described as above. This protocol from University of Michigan is one of those we referred to: https://macdougald.lab.medicine.umich.edu/lab-protocols/protocolsmethods/3t3-l1-differentiation-protocol
We followed the protocol strictly. While other people can have most of the cells differentiated after 4 days entering the third step, we are not able to reach a similar result, in other words we have a low differentiation rate (since it is weird so we worry if it could possibly affect our further research?)
We tried to troubleshoot. For example, our cell passage number isn't too high, we prepare the differentiation cocktail correctly, our cells have no mycoplasma infection, we tried different serum but all these seemed not effective. We also tried using the same medium and serum used by other groups from our institute who can efficiently differentiate,though there is a problem that their cells have mycoplasma, so we could not say for sure, but still we weren't able to reproduce their results either.
In this case, should we consider that the problem is with the cell we are using? We bought it from ATCC. We also have contacted the distributor and asked for relevant information, but we didn't see any obvious problems.
I think we are lost, please share any thoughts that maybe helpful, thank you!
Dear researchers,
We are starting a new experiment involving short chain fatty acids and we wanted to measure them in serum samples using UPLC-MS/MS.
For the protocol set up, we found some preliminary information, but we still need some details of the procedure, such as the proper gradient and column. Therefore, I was wondering if someone could shed some light about the technique and share with us the information about experimental procedure. I would really appreciate any further detail about it.
Thank you in advance for your time.
Javier Moleón Moya
Hello everyone,
I'm currently working on a project where I need to isolate viruses in culture from incubation with PCR-positive serum samples, but I'm facing the challenge of dissociating antibodies bound to the virus. Does anyone have a reliable protocol or references that could share for pre-treatment of infectious sample for isolation purposes?
Any guidance or suggestions would be greatly appreciated! Thank you in advance for your help.
Hi everyone,
I wanna get a suitable protocol for depletion of IgG and other immunoglobulins from serum, without kits or chromatography but with chemical methods like ammonium sulfate. Can anyone help me? Does anyone have any experiences about it?
Hi everyone,
I have some important problems with my western blot against serum proteins. I have used secondary antibody conjugated by HRP that binds in unspecific manner to other proteins as same position as my desired protein, like in 130, 180, 50, and 25 kD molecular weights. I have done over western blot without using primary antibody but using secondary antibody, and see these results.
What should I do that my secondary antibody don't bind to other proteins in PVDF?
Hello everyone,
Has anyone try to culture the normal prostate RWPE-1 cell line in RPMI medium supplemented with foetal bovine serum? There's some articles available but neither describe details about the adaptation process,
I would need an adaptation protocol or some technicals advices,
Thanks in advance,
Hi everyone,
I wanna do proteomics of monkeys serums in 2 states, healthy and patient. How many monkeys in each group I need to run proteomics and validate my data from it?
Do I deplete albumin and IgG from serum then run proteomics? or any extra purificaton steps? or I can run serum without any extra purification?
Thanks to answering me.
We have to report the concentration in pg/ml, the ELISA kit provider did not reveal the specific activity of the enzyme. In that case how to convert the units?
Researchers in the field of biochemistry often use it to study the effect of chemical compounds derived from medicinal plants and herbs, and their effect is studied in the laboratory on patient samples in serum or blood. The question is: what is the method that explains the effect of these compounds on enzymes and their work in the human body?
I am doing IL6 ELISA to measure mouse serum IL6, but my ODs are so low even for mouse on two weeks high fat diet.
My standard curve is good enough as a positive control.
Dear colleagues,
I will measure serum Ang 1, Ang 2 and VCAM-1 levels by ELISA in patients who were undergone hematopoietic stem cell transplantation. I should find the most suitable dilutions to be able to measure the cytokines' levels within the limits of the standards in the ELISA kit. I will try different dilutions, but I should use the wells of the kit as few as possible for the dilution optimization. Does anyone have any experience or recommendations which dilutions would be suitable while measuring serum Ang 1, Ang 2 and VCAM-1 levels?
Standard Curve Range for Ang 1 is 150-2400 pg/mL.
Standard Curve Range for Ang 2 is 40-640 ng/mL.
Standard Curve Range for VCAM-1 is 1.56-100 ng/mL.
Thank you very much for your help.
The journal about "The Transition From Gel Separatory Serum Tubes to Lithium Heparin Gel Tubes in The Clinical Laboratory” discussed how lithium heparin tubes did not show any significant differences from the normal gel separatory tubes. Are there other evacuated tubes that can be used aside from lithium heparin that can give significant laboratory results
In the journal, "THE TRANSITION FROM GEL SEPARATORY SERUM TUBES TO LITHIUM HEPARIN GEL TUBES IN THE CLINICAL LABORATORY" by Oğuzhan Zengi, In what ways does the use of LIH tubes impact laboratory workload and efficiency compared to traditional serum tubes, especially considering the potential benefits of reduced aspiration errors and false results?
I'm gonna to make arthritis model induce by serum from K/BxN. However, K/BxN mice are unable to breed. So where can I purchase K/BxN serum?
Hi,
I have having an issue with the Fc blocking stages when carrying out flow cytometry on a murine macrophage cell line. I am using a rat anti-mouse antibody against the scavenger receptor MARCO. Unfortunately, I have been unable to find a conjugated version of this antibody and so I have a secondary goat anti-rat F(ab')2 to use with it. I have an Fc blocking solution, however this is also raised in rats and causes non-specific binding as the F(ab')2 fragment binds to this blocking solution as well as the primary antibody. I have been unable to find any Fc blocking solutions that are not raised in rat and I have tried various serums to try and block the Fc receptors instead, but have been unsuccessful (I have used a variety of mouse, goat, and FBS combinations).
I was wondering if anyone knows of any Fc blocks that are not raised in rat I could try, or whether there is any advice on how to get good blocking results using serum?
Thanks very much!
We have received a new batch of SHSY5Y from the suppliers, and the cells are growing in clumps/spheres even after trypsinization.
Is there a way to control/stop it?
I just read this, and changing the brand of serum of adding more serum (>10%) may help?
I am conducting the IHC experiment with cultured cells.
However, I experienced the non-specific staining with all my samples.
The nucleus were stained by DAPI, but beside the blue of DAPI, they were also stained by the conjugated red-fluorescent dye of secondary antibody. I noticed that the cell nucleus was stained even much more strongly red than the other target parts. So when I merged two color images together, the red and blue signals overlapped, causing them to turn purple-pink. How to remove non-specific red staining of cell nucleus?
I put my image and our protocol below.
1. Fixation step: 4% Paraformaldehyde (PFA) 2ml, 20 min, Room Temp. --> 1. Washing with PBS (shaking) (3 times)
2. Permeation: 0.1% Triton in PBS for 10 min --> Washing with PBS (5min)
3. Blocking: 10% Serum in PBS, 1.5h
4. Primary antibody: Remove blocking solution, not washing --> Incubate cells in working solution of (0.1% Triton+10% Blocking Serum + Primary Antibody)/PBS (overnight, 4oC) (ratio 1:500)
5. Secondary antibody: Remove Primary antibody, wash 4 times with PBS --> Incubate cells in working solution of (0.1% Triton+10% Blocking Serum + Cy3-conjugated-Secondary Antibody (ratio 1:500) + DAPI (ratio 1:1000))
--> Washing 3 times with PBS

This question is related with the article written by Neuwinger, Nick et al. entitled “Underfilling of vacuum blood collection tubes leads to increased lactate dehydrogenase activity in serum and heparin plasma samples,” by examining the impact of blood collection techniques (venipuncture vs. IV catheterization) on hemolysis index and potassium concentration in samples. I seek to understand its implications for sample quality and laboratory testing.
This inquiry pertains to the study of Neuwinger, Nick et al. entitled "Underfilling of vacuum blood collection tubes results in elevated lactate dehydrogenase activity in serum and heparin plasma samples." I would like to know the effects of volume variation in blood samples on the accuracy of total cholesterol measurements in serum and heparin plasma samples.
In the laboratory, blood samples are often used to test for LDH. However, I want to know which sample is better as they are both blood samples.
The entire point of Oguzhan Zengi's study was to improve turnaround time and sample quality by exploring the less traditional option of plasma for the above reasons. The results did not suggest an outright replacement of serum, but showed many positives and reasoning for such.
In a way, one might say plasma has been neglected. This begs the question: what other potential sample variations could be used to improve TAT and sample quality?
According to the study conducted by Pan et al. (2023) entitled, “Diagnostic Efficacy of serological Antibody detection Tests for Hepatitis Delta Virus: A Systematic Review and Meta-Analysis,” what are the specimen considerations for the patient's serum in order to examine HDV antibodies present?
The journal published by Oguzhan Zengi entitled "The transition from gel separatory serum tubes to lithium heparin gel tubes in the clinical laboratory" aims to assess the viability of replacing serum with plasma samples. The study's lactate dehydrogenase (LDH) measurement conjures discrepancies in values between plasma and serum samples.
The journal "The transition from gel separatory serum tubes to lithium heparin gel tubes in the clinical laboratory" aims to assess the viability of replacing serum with plasma samples in different clinical chemistry and immunoassay tests, as well as to investigate the implications of turnaround time (TAT) and sample quality during the transition.
In the journal entitled "The Transition from Gel Separatory Serum Tubes to Lithium Heparin Gel Tubes in the Clinical Laboratory", how does transitioning from gel separatory serum tubes to lithium heparin gel tubes impact clinical laboratory efficiency and accuracy?
This question is derived from an article entitled "Underfilling of vacuum blood collection tubes leads to increased lactate dehydrogenase activity in serum and heparin plasma samples" by Neuwinger et. al. in 2019. I want to know how certain anticoagulants affect the lactate dehydrogenase activity in plasma or serum samples.
The research "The transition from gel separatory serum tubes to lithium heparin gel tubes in the clinical laboratory" is a study that aims to assess the viability of replacing serum samples with plasma samples in various clinical chemistry and immunoassay tests and to examine the implications of turnaround time (TAT) and sample quality during the transition process and a result of the study shows that there is a decreased TAT.
Oguzhan Zhengi, the sole author of the journal entitled “The Transition from Gel Separatory Serum Tubes to Lithium Heparin Gel Tubes in the Clinical Laboratory”, stated that a specific criteria was adhered to when handling the specimens. Throughout the Methodology, Zhengi explained the Clinical and Laboratory Standards Institute (CLSI) Criteria - GP34-A:2010. What was the content of this specific criteria and how did he utilize this document?
This question aims to understand the rationale behind the study, which likely sought to evaluate the comparability of gel separator serum and LIH plasma tubes in clinical chemistry and immunoassay tests. Additionally, it seeks insights into the study's findings concerning sample quality and turnaround time during the transition from serum to plasma samples, shedding light on the efficiency and reliability of different tube types in laboratory procedures.
In the journal, "THE TRANSITION FROM GEL SEPARATORY SERUM TUBES TO LITHIUM HEPARIN GEL TUBES IN THE CLINICAL LABORATORY" by Oğuzhan Zengi, how do the results of Bland-Altman plots and regression analysis contribute to our understanding of the comparability between serum tubes and LIH tubes for different clinical chemistry and immunoassay tests, and what implications do these findings have for clinical practice?
This question is derived from an article discussing the impact of underfilling of vacuum blood collection tubes on lactate dehydrogenase (LDH) activity in serum and heparin plasma samples
The cross-match test is an in vitro test to determine the presence of anti-lymphocyte antibody to donor cell antigens (lymphocytotoxic antibody) in serum of an individual with preformed antibodies to donor cells. Examples are recipients for an organ transplant or a couple with a history of recurrent spontaneous abortions. The recipient serum is incubated with donor lymphocytes and the binding can be detected by flow cytometry analysis (with fluorescent conjugated reagent). If cytotoxic antibodies are present in maternal serum, they will combine with the surface antigens of donor lymphocytes; the amount of fluorescence on the cells (percentage of positive T or B cells), as measured by flow cytometry, is proportional to the amount of antibody (flow cytometry cross-match).
This question is related to article authored by Neuwinger et. al. in 2019 entitled "Underfilling of vacuum blood collection tubes leads to increased lactate dehydrogenase activity in serum and heparin plasma samples.” Lactate dehydrogenase derives from many tissue sources making it a non-specific enzyme biomarker. In line with these, I want to seek out if the level of lactate dehydrogenase isoenzymes are affected by underfilled tubes?
This question is derived from the journal article “The Transition from Gel Separatory Serum to Lithium Heparin Gel Tubes in the Clinical Laboratory,” written by Oguzhan Zengi. The journal elaborated on the importance of switching to lithium heparin gel tubes in most clinical chemistry and immunoassay tests due to improved sample quality and decreased turnaround time (TAT) in the emergency laboratory.
I want to understand what the Warburg effect is and how it affects LDH activity in cancer.
I am looking suitable standard lipid for quantifying phosphatidylethanolamine (PE) from serum samples. As you may be aware, standard lipids, such as those derived from different sources (Soy, egg, brain etc), can have variations in their double bond positions. Could you please provide insights or recommendations on how to choose the most suitable standard lipid for our specific application?
I am planning to get some blood from patients to perform RNA seq (circular RNA which requires deep sequencing). I am wondering if anyone can share the protocol with details. I am also wondering about the amount of blood (whole / plasma / serum) to isolate RNA for deep sequencing. Thank you so much for your help!
I am planning an immunoprecipitation experiment using Mouse monoclonal [11C9] to Mannan Binding Lectin/MBL (ab26277) antibody to immunoprecipitate for MBL2 in human serum. There are many protocols online for immunoprecipitation utilising cell cultures, where the recommended amount of cells tends to be 10^6 to 10^7, however not so many that utilise human serum.
Reading online, the optimal total protein load of immunoprecipitation seems to be 1-5 mg/mL, with 0.1 mg/mL being the minimum recommended load. Considering that the normal range for total protein in human serum is 60-83g/L (average: 71.5 g/L), loading 5 mg of total protein for immunoprecipitation would mean I need 69.9 mL. Alternatively, loading the minimum (0.1 mg), I would need 1.395 mL of human serum based on my calculations.
I cannot afford to be using 1.395 mL of human serum in my experiment due to lack of sample volume. I was wondering if anyone can share the amount of human serum they've used for immunoprecipitation before, where it was successful. Thank you in advance.
I am using these product from ATCC (Primary Uterine Fibroblast Cells; Normal, Human (HUF) ATCC Cat. No. PCS-460-010 ) with their recommended media and with Growth Kit-Low Serum aacording to their recommendation. But I found the expression of alpha SMA, FAP and other CAF marker even without activation by cancer cell conditioned media. Please suggest me what to do ?
Hi everyone! I am used to doing BCA test while doing protein extraction from cells or tissue, but do you usually use it while working with serum, i.e. mouse serum? Or do you just consider your results from ELISA or dot blot according to 1 ul of serum?
The Advanced reduced serum DMEM/F12 works fine for my cell cultures, even without adding any serum at all. However, I'd like to find a medium similar to Advanced DMEM/F12 with a lower (only around 0.2-0.3 mM calcium concentration. The calcium concentration in Advanced DMEM/F12 is 1,05 mM).
The DMEM no calcium for example contains less ingredients (for instance proteins) than Advanced DMEM/F12 and is a "conventional" medium which requires 5-10% FBS supplement.
I'm looking for a medium with similar ingredients as Advanced reduced serum DMEM/F12 but no more than 0.3mM calcium , and which works without FCS supplementation or requires only very low FBS supplementation.
In the journal entitled “The Transition from Gel Separatory Serum Tubes to Lithium Heparin Gel Tubes in the Clinical Laboratory”, how is turnaround time measured in the study, and how did the transition into lithium heparin tubes affect its value, and why?
I am using mouse serum to block Fc receptors before staining, for flow cytometry. My question is if I should also add the serum to compensation beads before staining them, so that the cells and the beads go through the same processing.
Thank you very much in advance!
Hi all, I used Merk panels for luminex200 analysis on CSF, but of the same analytes I now don't have the corresponding validated panels on serum. Therefore I was wondering if possible to redo the same measurements using the luminex200 (millipore) with bio rad panels (or similar, proposals welcome)
Any complications? What is the acceptable range?
Hi everyone
I am currently investigating the effect of iron deficiency on neuronal cells (SHYSY5Y to be exact). For this, I need to create an environment of iron-depletion in-vitro. While past publications have used iron chelators in media, this involves considerable quality control. This is why I am choosing to mimic an iron-deficient environment through serum starvation.
I am currently struggling to find publications outlining a validated method of serum starvation to achieve this, which would be of great help, as a trial- and error method in the lab is time consuming. Another concern is that other essential nutrients would also be depleted with serum starvation, that may affect any findings and therefore impact the validity of results. I am also interested in any iron-depleted media out there that I could potentially use?
Would greatly appreciate any advice, links to publications or methods I could follow.
In the Journal "The transition from gel separatory serum tubes to lithium heparin gel tubes in the clinical laboratory" the researchers found discrepancies in regard to the effects of plasma insulin but failed to expound on that information. It was included in their limitations that Insulin TE value did not exceed TEa, but it consumed near all its error budget. It was also stated that further studies should also evaluate insulin values at low, normal, and high levels for a more thorough comprehension.
I have tried 4 IBA1 antibodies and cannot seem to get good staining. Mice were perfused/fixed with PBS/4%PFA. Brains were placed in PFA overnight, and then moved to 30% sucrose and frozen in OCT after sinking. My sections typically tend to be thicker (30um or 35um), but we do sections on slides instead of free-floating due to less handling and integrity of the structures. All of my antibodies work except for these IBA1 antibodies. I have tried permeabilizing with triton and saponin and got similar results. (Fix for 5 minutes on slide with 2% PFA, perm with 0.3% triton 15 min, block with 10% goat serum 30 minutes, then primary and secondary incubations with blocking serum). Antibodies are spun before addition.
Can anyone advise me as to why these IBA1 antibodies are creating so much background at both 1:100 and 1:1000, and why it is not staining the filaments of the microglia? Any advice is greatly appreciated.
Note: Serum isolated extracellular vesicles using immunoprecipitation (magnetic beads)
This inquiry is related to a 2019 journal article authored by Nick Neuwinger et al., which explores the effect of underfilling vacuum blood collection tubes on the elevation of lactate dehydrogenase activity in both serum and heparin plasma samples. The conclusion drawn is that underfilling tubes causes a larger portion of blood to be aspirated at high velocity, resulting in elevated lactate dehydrogenase levels.
Nick Neuwinger et al. (October 2019) Underfilling of vacuum blood collection tubes leads to increased lactate dehydrogenase activity in serum and heparin plasma samples Retrieved on February 06, 2024 from
Hi, we were told that we could use this panel to measure cytokines in CSF, but the protocol was to use only serum and plasma. We contacted Merk technical service who told us to test some dilutions to find the optimal sample dilution factor. Has anyone used this panel with CSF before? What dilutions were adopted?
JEG-3 cells were cultured in DMEM F-12 medium with 10% FBS and 1% penicillin/streptomycin for 24 h. Cells were serum starved (in DMEM F-12 with 0,1% BSA and 1% penicillin/streptomycin) for 72 h (medium was changed every 48h). Ater 48h without serum the cells were changing their morphology and according to WST-1 test their viability was poor. Do you have any suggestions how to culture cells in conditions without serum?
Hi I'm relatively new to the field,
I would like to minimise sample collection from patients but I need to test cytokines and circulating antibodies in serum while also isolating PBMCs
If I collect blood with with a vacutainer with a red top suited for serological studies can I also extract PBMCs? or should I ask for two tubes red and yellow?
Thanks
Total Media constituents:
Media = RPMI and DMEM/F-12
Bovine Calf Serum
Streptomycin
Amphotericin B
Although Oğuzhan Zengi (2023) has explored the practicality and technical aspects of shifting from gel serum tubes to lithium heparin (LIH) gel tubes in clinical laboratories, there is still a gap in understanding the impact on patient outcomes and healthcare quality.
The journal paper "The transition from gel separatory serum tubes to lithium heparin tubes in the clinical laboratory" discusses the advantages of lithium heparin over the traditional gel separatory serum tubes, which is the focus of this question is that why the does laboratories still prefer gel separatory serum tubes?
The question is based on the findings of a study comparing serum and LIH tubes in clinical chemistry and immunoassay tests. The study suggests that LIH tubes can effectively substitute serum tubes for most tests, except LDH, and that LIH plasma tubes enhance sample quality, reduce turnaround time (TAT), and decrease the incidence of aspiration errors in emergency laboratory settings.